PDC*LINE PHARMA CEO WILL MAKE A PRESENTATION AT THE 6TH EUROPE NEOANTIGEN SUMMIT IN AMSTERDAM!
![](/sites/default/files/images/Eric%20Halioua_0.png)
We are delighted to announce that our CEO will be presenting at the 6th Europe Neoantigen Summit 2023 hosted by Hanson Wade in Amsterdam (Netherlands) from April 24-26th! He will be presenting PDC*line Pharma unique cancer vaccine platform and the first results of our on-going phase I/II clinical trial in Non-Small Cell Lung Cancer.
Learn more here: www.neoantigen-europe.com
About the Summit:
The 6th Europe Neoantigen Summit is the leading industry-dedicated meeting that supercharges the translation of personalized neoantigen & shared antigen vaccines through robust prediction, enhanced identification, and critical validation to improve the accessibility and efficacy of patient care.